| Released | Contributor | Author | Title | Pages | Price |
| 29-Nov-2009 | Wright Reports |
N/A
| Wright Investors Service Comprehensive Report for Novabay Pharmaceuticals, Inc. | 40 |
$65 |
| 27-Nov-2009 | Pechala's Reports | Lubomir Pechala | NOVABAY PHARMACEUTICALS INC (NBY=US) 2-weeks forecast | 1 |
$10 |
| 27-Nov-2009 | Pechala's Reports | Frantisek Pechala | NOVABAY PHARMACEUTICALS INC (NBY=US) 12-months forecast | 1 |
$15 |
| 26-Nov-2009 | Ford Investor Services, Inc. |
N/A
| Value Graph: NOVABAY PHARMA -- NBY | 1 |
$4 |
| 26-Nov-2009 | Ford Investor Services, Inc. |
N/A
| Industry Value Graph: AIS , APPA , CPRX , NLTX , NBY , PCYC , VRUS , DDD -- DRUGS | 3 |
$4 |
| 23-Nov-2009 | Reuters Investment Profile |
N/A
| NovaBay Pharmaceuticals Inc: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis. | 12 |
$20 |
| 23-Nov-2009 | ValuEngine, Inc. |
N/A
| ValuEngine Detailed Valuation Report for NBY | 13 |
$25 |
| 21-Nov-2009 | TheStreet.com Ratings |
N/A
| TheStreet.com Ratings Stock Report For: NOVABAY PHARMACEUTICALS INC | 5 |
$25 |
| 14-Nov-2009 | TheStreet.com Ratings |
N/A
| TheStreet.com Ratings Stock Report For: NOVABAY PHARMACEUTICALS INC | 5 |
$25 |
| 13-Nov-2009 | Zacks Investment Research Inc. |
N/A
| NOVABAY PHARMAC (NBY) Zacks Company Snapshot | 1 |
$10 |
1.48% Nasdaq 0.00%
Research Reports
